456 related articles for article (PubMed ID: 9217656)
41. The epidemiology of genital human papillomavirus infection.
Trottier H; Franco EL
Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence.
Svare EI; Kjaer SK; Worm AM; Osterlind A; Moi H; Christensen RB; Meijer CJ; Walboomers JM; van den Brule AJ
Int J Cancer; 1998 Jan; 75(1):1-8. PubMed ID: 9426682
[TBL] [Abstract][Full Text] [Related]
43. Impact of HPV infection in adolescent populations.
Moscicki AB
J Adolesc Health; 2005 Dec; 37(6 Suppl):S3-9. PubMed ID: 16310138
[TBL] [Abstract][Full Text] [Related]
44. [Human Papilloma virus. Epidemiologic, carcinogenic, diagnostic and therapeutic aspects].
Vargas-Hernández VM
Ginecol Obstet Mex; 1996 Sep; 64():411-7. PubMed ID: 8964543
[TBL] [Abstract][Full Text] [Related]
45. [Human papilloma virus infection in vaginal condyloma acuminatum].
Tsuji K; Nakamura Y; Mori I; Tanaka M
Rinsho Byori; 2003 Feb; 51(2):93-7. PubMed ID: 12690625
[TBL] [Abstract][Full Text] [Related]
46. Human papillomavirus infection and cervical cancer in Brazil: a retrospective study.
Cavalcanti SM; Deus FC; Zardo LG; Frugulhetti IC; Oliveira LH
Mem Inst Oswaldo Cruz; 1996; 91(4):433-40. PubMed ID: 9070405
[TBL] [Abstract][Full Text] [Related]
47. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types?
Kjaer SK; van den Brule AJ; Bock JE; Poll PA; Engholm G; Sherman ME; Walboomers JM; Meijer CJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):799-805. PubMed ID: 9332762
[TBL] [Abstract][Full Text] [Related]
48. The Prevalence and Genotype of Human Papillomavirus from Patients with Genital Warts in Eastern Guangdong Province.
Luo ZY; Chen Q; Yang H; Lin M; Chen CY; Yang C; Yang LY
Asian Pac J Cancer Prev; 2015; 16(14):5675-9. PubMed ID: 26320434
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.
Winer RL; Hughes JP; Feng Q; Xi LF; Lee SK; O'Reilly SF; Kiviat NB; Koutsky LA
Sex Transm Dis; 2012 Nov; 39(11):848-56. PubMed ID: 23064533
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology of human papillomavirus infections.
Beutner KR; Becker TM; Stone KM
Dermatol Clin; 1991 Apr; 9(2):211-8. PubMed ID: 1647901
[TBL] [Abstract][Full Text] [Related]
51. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
52. Distribution of genital human papillomavirus genotypes in benign clinical manifestations among men from Northern Spain.
Arroyo LS; Basaras M; Arrese E; Hernáez S; Esteban V; Cisterna R
BMC Public Health; 2016 Jan; 16():81. PubMed ID: 26817692
[TBL] [Abstract][Full Text] [Related]
53. Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients.
Brown DR; Bryan JT; Cramer H; Katz BP; Handy V; Fife KH
J Infect Dis; 1994 Oct; 170(4):759-65. PubMed ID: 7930715
[TBL] [Abstract][Full Text] [Related]
54. Hand-genital transmission of genital warts? An analysis of prevalence data.
Fairley CK; Gay NJ; Forbes A; Abramson M; Garland SM
Epidemiol Infect; 1995 Aug; 115(1):169-76. PubMed ID: 7641831
[TBL] [Abstract][Full Text] [Related]
55. HPV 16 antibody prevalence in Jamaica and the United States reflects differences in cervical cancer rates.
Strickler HD; Kirk GD; Figueroa JP; Ward E; Braithwaite AR; Escoffery C; Drummond J; Goebel B; Waters D; McClimens R; Manns A
Int J Cancer; 1999 Jan; 80(3):339-44. PubMed ID: 9935171
[TBL] [Abstract][Full Text] [Related]
56. Natural history of cervical infection with human papillomaviruses.
Morrison EA
Clin Infect Dis; 1994 Feb; 18(2):172-80. PubMed ID: 8161623
[TBL] [Abstract][Full Text] [Related]
57. Understanding genital warts: epidemiology, pathogenesis, and burden of disease of human papillomavirus.
Bhatia N; Lynde C; Vender R; Bourcier M
J Cutan Med Surg; 2013 Dec; 17 Suppl 2():S47-54. PubMed ID: 24388558
[TBL] [Abstract][Full Text] [Related]
58. Determinants of genital human papillomavirus detection in a US population.
Peyton CL; Gravitt PE; Hunt WC; Hundley RS; Zhao M; Apple RJ; Wheeler CM
J Infect Dis; 2001 Jun; 183(11):1554-64. PubMed ID: 11343204
[TBL] [Abstract][Full Text] [Related]
59. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.
Giuliano AR; Tortolero-Luna G; Ferrer E; Burchell AN; de Sanjose S; Kjaer SK; Muñoz N; Schiffman M; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 10(0 10):K17-28. PubMed ID: 18847554
[TBL] [Abstract][Full Text] [Related]
60. Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.
Viscidi RP; Kotloff KL; Clayman B; Russ K; Shapiro S; Shah KV
Clin Diagn Lab Immunol; 1997 Mar; 4(2):122-6. PubMed ID: 9067643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
